Indian share market to outperform economy; IT, pharma stocks in good spot, but stretched valuations a concern

Despite the muted outlook due to the second wave, NIFTY earnings’ estimates for FY22 / FY23 are largely unchanged

from The Financial Express https://ift.tt/3oZfB3S
https://ift.tt/eA8V8J